These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


338 related items for PubMed ID: 14673764

  • 21. Incidence and outcome of primary Epstein-Barr virus infection and lymphoproliferative disease in pediatric heart transplant recipients.
    Zangwill SD, Hsu DT, Kichuk MR, Garvin JH, Stolar CJ, Haddad J, Stylianos S, Michler RE, Chadburn A, Knowles DM, Addonizio LJ.
    J Heart Lung Transplant; 1998 Dec; 17(12):1161-6. PubMed ID: 9883755
    [Abstract] [Full Text] [Related]

  • 22. Comparison of serum and whole blood levels of cytomegalovirus and Epstein-Barr virus DNA.
    Kullberg-Lindh C, Olofsson S, Brune M, Lindh M.
    Transpl Infect Dis; 2008 Oct; 10(5):308-15. PubMed ID: 18466193
    [Abstract] [Full Text] [Related]

  • 23. The value of prospective monitoring of Epstein-Barr virus DNA in blood samples of pediatric liver transplant recipients.
    Scheenstra R, Verschuuren EA, de Haan A, Slooff MJ, The TH, Bijleveld CM, Verkade HJ.
    Transpl Infect Dis; 2004 Mar; 6(1):15-22. PubMed ID: 15225222
    [Abstract] [Full Text] [Related]

  • 24. Monitoring of Epstein-Barr viral load in pediatric heart and lung transplant recipients by real-time polymerase chain reaction.
    Benden C, Aurora P, Burch M, Cubitt D, Lloyd C, Whitmore P, Neligan SL, Elliott MJ.
    J Heart Lung Transplant; 2005 Dec; 24(12):2103-8. PubMed ID: 16364857
    [Abstract] [Full Text] [Related]

  • 25. Dynamic EBV gene loads in renal, hepatic, and cardiothoracic transplant recipients as determined by real-time PCR light cycler.
    Leung E, Shenton BK, Green K, Jackson G, Gould FK, Yap C, Talbot D.
    Transpl Infect Dis; 2004 Dec; 6(4):156-64. PubMed ID: 15762933
    [Abstract] [Full Text] [Related]

  • 26. Significance of detecting Epstein-Barr-specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients.
    Krieger NR, Martinez OM, Krams SM, Cox K, So S, Esquivel CO.
    Liver Transpl; 2000 Jan; 6(1):62-6. PubMed ID: 10648579
    [Abstract] [Full Text] [Related]

  • 27. Epstein-Barr virus load in transplant patients: Early detection of post-transplant lymphoproliferative disorders.
    Fellner MD, Durand KA, Solernou V, Bosaleh A, Balbarrey Z, García de Dávila MT, Rodríguez M, Irazu L, Alonio LV, Picconi MA.
    Rev Argent Microbiol; 2016 Jan; 48(2):110-8. PubMed ID: 27157146
    [Abstract] [Full Text] [Related]

  • 28. Epstein-Barr virus load in whole blood is associated with immunosuppression, but not with post-transplant lymphoproliferative disease in stable adult heart transplant patients.
    Doesch AO, Konstandin M, Celik S, Kristen A, Frankenstein L, Sack FU, Schnabel P, Schnitzler P, Katus HA, Dengler TJ.
    Transpl Int; 2008 Oct; 21(10):963-71. PubMed ID: 18564989
    [Abstract] [Full Text] [Related]

  • 29. Epstein-Barr virus gene expression in the peripheral blood of transplant recipients with persistent circulating virus loads.
    Qu L, Green M, Webber S, Reyes J, Ellis D, Rowe D.
    J Infect Dis; 2000 Oct; 182(4):1013-21. PubMed ID: 10979894
    [Abstract] [Full Text] [Related]

  • 30. Real-time polymerase chain reaction (RQ-PCR) for the monitoring of Epstein-Barr virus (EBV) load in peripheral blood mononuclear cells.
    Wagner HJ, Jabs W, Smets F, Wessel M, Fischer L, Offner G, Kirchner H, Bucsky P.
    Klin Padiatr; 2000 Oct; 212(4):206-10. PubMed ID: 10994552
    [Abstract] [Full Text] [Related]

  • 31. A randomized trial of ganciclovir versus ganciclovir plus immune globulin for prophylaxis against Epstein-Barr virus related posttransplant lymphoproliferative disorder.
    Humar A, Hébert D, Davies HD, Humar A, Stephens D, O'Doherty B, Allen U.
    Transplantation; 2006 Mar 27; 81(6):856-61. PubMed ID: 16570008
    [Abstract] [Full Text] [Related]

  • 32. Epstein-Barr viral load in whole blood of adults with posttransplant lymphoproliferative disorder after solid organ transplantation does not correlate with clinical course.
    Oertel S, Trappe RU, Zeidler K, Babel N, Reinke P, Hummel M, Jonas S, Papp-Vary M, Subklewe M, Dörken B, Riess H, Gärtner B.
    Ann Hematol; 2006 Jul 27; 85(7):478-84. PubMed ID: 16586109
    [Abstract] [Full Text] [Related]

  • 33. Quantification of a low cellular immune response to aid in identification of pediatric liver transplant recipients at high-risk for EBV infection.
    Lee TC, Goss JA, Rooney CM, Heslop HE, Barshes NR, Caldwell YM, Gee AP, Scott JD, Savoldo B.
    Clin Transplant; 2006 Jul 27; 20(6):689-94. PubMed ID: 17100717
    [Abstract] [Full Text] [Related]

  • 34. Decreasing the Epstein-Barr virus load by adjusting the FK506 blood level.
    Orii T, Ohkohchi N, Satomi S, Hoshino Y, Kimura H.
    Transpl Int; 2002 Nov 27; 15(11):529-34. PubMed ID: 12461655
    [Abstract] [Full Text] [Related]

  • 35. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
    Colombini E, Guzzo I, Morolli F, Longo G, Russo C, Lombardi A, Merli P, Barzon L, Murer L, Piga S, Ciofi Degli Atti ML, Locatelli F, Dello Strologo L.
    Pediatr Nephrol; 2017 Aug 27; 32(8):1433-1442. PubMed ID: 28280938
    [Abstract] [Full Text] [Related]

  • 36. The impact of monitoring Epstein-Barr virus PCR in paediatric bone marrow transplant patients: can it successfully predict outcome and guide intervention?
    Greenfield HM, Gharib MI, Turner AJ, Guiver M, Carr T, Will AM, Wynn RF.
    Pediatr Blood Cancer; 2006 Aug 27; 47(2):200-5. PubMed ID: 16206207
    [Abstract] [Full Text] [Related]

  • 37. Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders.
    Jabs WJ, Hennig H, Kittel M, Pethig K, Smets F, Bucsky P, Kirchner H, Wagner HJ.
    J Clin Microbiol; 2001 Feb 27; 39(2):564-9. PubMed ID: 11158107
    [Abstract] [Full Text] [Related]

  • 38. [Evaluation of PCR results in the diagnosis of Epstein-Barr virus infections].
    Karadağ Geçgel S, Ersoy A, Sevinir BB, Sınırtaş M, Göral G.
    Mikrobiyol Bul; 2012 Oct 27; 46(4):594-606. PubMed ID: 23188573
    [Abstract] [Full Text] [Related]

  • 39. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection.
    Bauer CC, Aberle SW, Popow-Kraupp T, Kapitan M, Hofmann H, Puchhammer-Stöckl E.
    J Med Virol; 2005 Jan 27; 75(1):54-8. PubMed ID: 15543583
    [Abstract] [Full Text] [Related]

  • 40. Preemptive diagnosis and treatment of Epstein-Barr virus-associated post transplant lymphoproliferative disorder after hematopoietic stem cell transplant: an approach in development.
    Weinstock DM, Ambrossi GG, Brennan C, Kiehn TE, Jakubowski A.
    Bone Marrow Transplant; 2006 Mar 27; 37(6):539-46. PubMed ID: 16462755
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 17.